GB0621848D0 - Assay method - Google Patents

Assay method

Info

Publication number
GB0621848D0
GB0621848D0 GB0621848A GB0621848A GB0621848D0 GB 0621848 D0 GB0621848 D0 GB 0621848D0 GB 0621848 A GB0621848 A GB 0621848A GB 0621848 A GB0621848 A GB 0621848A GB 0621848 D0 GB0621848 D0 GB 0621848D0
Authority
GB
United Kingdom
Prior art keywords
assay method
assay
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0621848A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fusion Antibodies Ltd
Original Assignee
Fusion Antibodies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fusion Antibodies Ltd filed Critical Fusion Antibodies Ltd
Priority to GB0621848A priority Critical patent/GB0621848D0/en
Publication of GB0621848D0 publication Critical patent/GB0621848D0/en
Priority to CA002683109A priority patent/CA2683109A1/en
Priority to AU2007306139A priority patent/AU2007306139B2/en
Priority to EP07824835A priority patent/EP2087113A2/en
Priority to PCT/GB2007/050623 priority patent/WO2008044068A2/en
Priority to JP2009531923A priority patent/JP5919593B2/en
Priority to NZ576119A priority patent/NZ576119A/en
Priority to US12/445,109 priority patent/US20100111965A1/en
Ceased legal-status Critical Current

Links

GB0621848A 2006-10-11 2006-11-02 Assay method Ceased GB0621848D0 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
GB0621848A GB0621848D0 (en) 2006-11-02 2006-11-02 Assay method
CA002683109A CA2683109A1 (en) 2006-10-11 2007-10-11 Combination therapy
AU2007306139A AU2007306139B2 (en) 2006-10-11 2007-10-11 Combination therapy
EP07824835A EP2087113A2 (en) 2006-10-11 2007-10-11 Combination therapy
PCT/GB2007/050623 WO2008044068A2 (en) 2006-10-11 2007-10-11 Combination therapy
JP2009531923A JP5919593B2 (en) 2006-10-11 2007-10-11 Combination therapy
NZ576119A NZ576119A (en) 2006-10-11 2007-10-11 Combination therapy involving egf inhibitors
US12/445,109 US20100111965A1 (en) 2006-10-11 2007-10-11 Combination therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0621848A GB0621848D0 (en) 2006-11-02 2006-11-02 Assay method

Publications (1)

Publication Number Publication Date
GB0621848D0 true GB0621848D0 (en) 2006-12-13

Family

ID=37547210

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0621848A Ceased GB0621848D0 (en) 2006-10-11 2006-11-02 Assay method

Country Status (1)

Country Link
GB (1) GB0621848D0 (en)

Similar Documents

Publication Publication Date Title
IL194892A0 (en) Nonseparation assay methods
PL2021778T3 (en) Nonseparation assay methods
GB0601961D0 (en) Method
GB0603081D0 (en) Method
GB0606147D0 (en) Method
GB0605323D0 (en) Method
IL196268A0 (en) Assay methods
GB0603008D0 (en) Method
GB0604018D0 (en) Method
GB0601699D0 (en) Method
GB0602986D0 (en) Method
EP1991873A4 (en) Separation-free assay method
GB0608446D0 (en) Assay
GB0600031D0 (en) Assay
GB0615813D0 (en) Assay
GB0502065D0 (en) Assay method
GB0720672D0 (en) Assay method
GB0623892D0 (en) Assay
GB0607462D0 (en) Assay
GB0511893D0 (en) Assay method
GB0621272D0 (en) Assay and method
GB0603036D0 (en) Method
GB0602830D0 (en) Method
GB0621848D0 (en) Assay method
GB0604682D0 (en) Assay Method

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)